SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-23-004792
Filing Date
2023-03-28
Accepted
2023-03-28 16:02:51
Documents
84
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K crvs-20221231x10k.htm   iXBRL 10-K 2544753
2 EX-21.1 crvs-20221231xex21d1.htm EX-21.1 6205
3 EX-23.1 crvs-20221231xex23d1.htm EX-23.1 1978
4 EX-31.1 crvs-20221231xex31d1.htm EX-31.1 14096
5 EX-31.2 crvs-20221231xex31d2.htm EX-31.2 14495
6 EX-32.1 crvs-20221231xex32d1.htm EX-32.1 7392
7 GRAPHIC crvs-20221231x10k007.jpg GRAPHIC 78653
8 GRAPHIC crvs-20221231x10k008.jpg GRAPHIC 58668
9 GRAPHIC crvs-20221231x10k009.jpg GRAPHIC 41797
  Complete submission text file 0001558370-23-004792.txt   9522705

Data Files

Seq Description Document Type Size
10 EX-101.SCH crvs-20221231.xsd EX-101.SCH 54334
11 EX-101.CAL crvs-20221231_cal.xml EX-101.CAL 65648
12 EX-101.DEF crvs-20221231_def.xml EX-101.DEF 174661
13 EX-101.LAB crvs-20221231_lab.xml EX-101.LAB 516001
14 EX-101.PRE crvs-20221231_pre.xml EX-101.PRE 368258
78 EXTRACTED XBRL INSTANCE DOCUMENT crvs-20221231x10k_htm.xml XML 1574910
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37719 | Film No.: 23769450
SIC: 2834 Pharmaceutical Preparations